Table 4.
Characteristics | Clinical pregnancy | ||
---|---|---|---|
|
No |
Yes |
pvalue* |
|
Median [IQR] |
Median [IQR] |
|
Age (years) |
36.00 (33.00, 37.00) |
38.00 (36.00, 44.00) |
0.069 |
FSH (IU/L) |
6.3 (5.50, 7.90) |
5.5 (4.10, 8.50) |
0.634 |
PRL (ng/mL) |
12.10 (7.20, 16.1) |
19.20 (11.70, 22.60) |
0.054 |
Total gonadotropin dosage |
3,075.00 (2,275.00, 3,675.00) |
2,625.00 (2,325.00, 3,175.00) |
0.398 |
Estradiol, 5th day of rFSH administration (pg/mL) |
400.00 (252.00, 691.00) |
450.00 (309.00, 509.00) |
0.572 |
Estradiol, peak (pg/mL) |
2,022.00 (1,561.00, 2,569.00) |
2,188.50 (1,254.00, 2,805.00) |
0.686 |
Number of oocytes retrieved |
8.00 (6.00, 10.00) |
9.00 (6.00, 10.00) |
0.765 |
Mature oocyte ratio (%) |
71.00 (60.00, 78.00) |
68.50 (67.00, 83.00) |
1.000 |
Survivin/ABL | 0.50 (0.20, 3.00) | 0.3 (0.20, 1.20) | 0.246 |
*Statistical Test.
Clinical pregnancy in correlation with patients’ cycle characteristics and survivin/ABL genes expression.